KURAClinical Trials•globenewswire•September 3, 2025 at 12:02 PM

Kura Oncology to Host Virtual Investor and Analyst Events on Farnesyl Transferase Inhibitor Program

Sentiment:Negative (20)

(NASDAQ:KURA) September 16 event to highlight preclinical data on the combination of FTI agents with multiple classes of targeted therapies

Read the full article from the original source for complete details and context.

Article published on September 3, 2025 by globenewswire